Laminar partners with charity Sonrisa Médica to bring joy to hospitalised children
Laminar Pharma has signed an agreement to sponsor the charity Sonrisa Médica, whose mission is to ma...
05 May, 2021-
Next generation medicinesLearn moreWe design and develop drugs based on a novel therapeutic approach called melitherapy. -
A new pharmaceutical perspectiveLearn moreOur drugs are first-in-class molecules which target membrane lipids, instead of acting directly on proteins or DNA like other medicines.
-
Committed
to peopleLearn moreOur goal is to deliver reference treatments for illnesses with unmet medical needs, such as cancer and Alzheimer’s disease.
